Sponsored Links
Lymphoma Information Network » Lymphoma Info » Primary Lymphoma of Bone

Primary Lymphoma of Bone

The terms "-Hodgkin's lymphoma" and "-Hodgkin lymphoma" are used interchangeably on this site

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid tissue (MALT)). It is hard to believe but the bones are an important part of the lymphatic process: the "B" in white b-cell is for cell maturation in the bone marrow.

Lymphomas (Nonhodgkin's mostly, rarely Hodgkin's lymphoma) can start in the bone. These lymphomas are all quite rare, 1-3% of bone tumors. The lymphoma can be an aggressive one or an indolent form. These are not to be confused with lymphomas that have spread to the bone from other areas.

Lymphoma of bone strikes more men than women (4:3 ratio). They can occur at all ages but is rare in pediatric (childhood) patients. 20% of cases are adults in their 60s.

Symptoms

The main symptom is localized pain which has been present for months if not years. The area of the primary tumor may be tender or swell. Fever and weight loss do not occur.

Treatment

If the tumor is localized, chemotherapy and/or radiotherapy may be given. The oncologist may elect to surgically remove the affected bone. Radiation may be given if local lymph nodes are involved where as chemotherapy may be called for for disease that has spread. Exact treatment will be determined by your doctor based on what testing finds.

Sponsored Links

Cancer Support Groups

SupportGroups.com builds awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Clinical Trial Locator

Pharmatech Oncology assists lymphoma patients in identifying clinical studies. Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Non-Hodgkin Lymphoma Information Pages:

Hodgkin's Lymphoma Page

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries

Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.
lymphomas